Liquidia Technologies is trading at $68.42, up 4.10%, with no new company-specific announcement dated September 16, 2026 identified.
- Latest listed releases: September 3 FDA Fast Track designation for YUTREPIA and a September 2 conference presentation announcement.
- Nasdaq is up 0.73%, while biotechnology is down 2.11%, making sector-wide momentum an unlikely primary explanation.